Found: 5
Select item for more details and to access through your institution.
Aptamer‐Engineered Natural Killer Cells for Cell‐Specific Adaptive Immunotherapy.
- Published in:
- Small, 2019, v. 15, n. 22, p. 1, doi. 10.1002/smll.201900903
- By:
- Publication type:
- Article
Novel Linguistic Steganography Based on Character-Level Text Generation.
- Published in:
- Mathematics (2227-7390), 2020, v. 8, n. 9, p. 1558, doi. 10.3390/math8091558
- By:
- Publication type:
- Article
Anterior Cruciate Ligament Reconstruction in a Rabbit Model Using a Decellularized Allogenic Semitendinous Tendon Combined with Autologous Bone Marrow‐Derived Mesenchymal Stem Cells.
- Published in:
- Stem Cells Translational Medicine, 2019, v. 8, n. 9, p. 971, doi. 10.1002/sctm.18-0132
- By:
- Publication type:
- Article
Hymeglusin Enhances the Pro-Apoptotic Effects of Venetoclax in Acute Myeloid Leukemia.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.864430
- By:
- Publication type:
- Article
ssDNA Aptamer Specifically Targets and Selectively Delivers Cytotoxic Drug Doxorubicin to HepG2 Cells.
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0147674
- By:
- Publication type:
- Article